Analyzing MASLD interventional clinical trial registration based on the ClinicalTrials.gov database
This study suggests the basic characteristics of global MASLD clinical trial design, and the current global interventional clinical trials are mainly focused on drug-related treatments, and drugs to improve inflammation and metabolism are still the first choice for MASLD drug intervention studies.
Authors
- Qianmin Su (ORCID: https://orcid.org/0000-0002-9885-6485)
- Yiqun Wang (ORCID: https://orcid.org/0000-0002-1457-0085)
- Luming Hou
- Jihan Huang (ORCID: https://orcid.org/0000-0002-2176-737X)
- Yali Li
- Ying Li (ORCID: https://orcid.org/0000-0001-9040-5201)
- Chunyan Wang (ORCID: https://orcid.org/0000-0003-3218-2083)
- Youhua Wang (ORCID: https://orcid.org/0000-0001-7626-3315)
- Hui Du
Institutions
- Shanghai University of Engineering Science (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN)
- Shanghai Public Health Clinical Center (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1186/s12876-025-03732-2
- Citations
- 3
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.06
Funders
- Longhua Hospital Shanghai University of Traditional Chinese Medicine